Mode
Text Size
Log in / Sign up

Disease progression and death in a 10 year old male with lower esophageal squamous cell carcinomaRare case: child dies 7 months after esophageal cancer diagnosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that pediatric esophageal squamous cell carcinoma often presents at an advanced stage with poor prognosis.

This case report and retrospective literature analysis focuses on a single 10 year old male patient diagnosed with lower esophageal squamous cell carcinoma. The clinical course involved interventions including chemotherapy and laparoscopic gastrostomy.

The primary outcome measured was disease progression and survival. The patient experienced disease progression and died 7 months after diagnosis. No specific p-values or confidence intervals were reported for this outcome.

Safety and tolerability data, including specific adverse events or discontinuation rates, were not reported. The clinical relevance of this case is constrained by the fact that clinical reports on esophageal cancer in children are extremely scarce. Current available evidence is derived primarily from adult studies and isolated pediatric case reports.

While no standardized treatment exists for pediatric esophageal squamous cell carcinoma, a comprehensive approach combining neoadjuvant chemoradiotherapy with surgery may be cautiously considered in selected pediatric patients. However, the prognosis for this condition is often poor, as the disease is frequently diagnosed at an advanced stage.

A new case report describes a 10-year-old boy diagnosed with a rare form of esophageal cancer called lower esophageal squamous cell carcinoma. The child received chemotherapy and a feeding tube, but the disease progressed, and he died 7 months after diagnosis. This case is one of very few reports of this cancer in children.

Esophageal cancer is extremely rare in children, and most of what doctors know comes from studies in adults. Because of this, there are no standard treatments for children with this disease. The report suggests that a combination of chemotherapy, radiation, and surgery might be considered for some children, but more research is needed.

The main limitation of this report is that it describes only one patient. The findings cannot be generalized to all children with esophageal cancer. The authors note that clinical reports on this cancer in children are extremely scarce, and available evidence comes mostly from adult studies.

For parents and families, this case underscores the seriousness of this rare cancer and the need for more research. If you have concerns about your child's health, talk to a doctor. This report does not provide medical advice.

What this means for you:
Esophageal cancer in children is very rare and often deadly, with no standard treatment.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Malignant solid tumors of the gastrointestinal tract are clinically rare in children, with malignant solid tumors of the esophagus being particularly uncommon. Clinical reports on esophageal cancer in children are extremely scarce. This report describes a case of lower esophageal squamous cell carcinoma in a 10-year-old male child. By integrating the clinical management process and relevant literature, we analyze the clinical characteristics, diagnostic and therapeutic key points, and prognostic factors of pediatric esophageal squamous cell carcinoma, aiming to provide reference for its clinical management. The patient was admitted for “vomiting for 1 month” and diagnosed with stage IIIA (T1N2M0) squamous cell carcinoma of the lower esophagus. Despite treatment including chemotherapy and laparoscopic gastrostomy, the disease progressed, and the patient died 7 months after diagnosis. Pediatric esophageal squamous cell carcinoma is often diagnosed at an advanced stage with poor prognosis. Its clinical manifestations lack specificity, and no definitive treatment protocol currently exists. It differs significantly from adult tumors in clinical presentation and management strategies, not merely representing a “miniature version” of adult tumors. Currently, no standardized treatment exists for pediatric esophageal squamous cell carcinoma. Available evidence, derived primarily from adult studies and isolated pediatric case reports, suggests that a comprehensive approach combining neoadjuvant chemoradiotherapy with surgery may be cautiously considered in selected pediatric patients. Delaying surgery until tumor downstaging and optimal surgical timing are achieved may potentially improve survival outcomes for these patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.